Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,058
Closed -$542K 237
2022
Q1
$542K Buy
7,058
+100
+1% +$7.19K 0.03% 113
2021
Q4
$533K Buy
+6,958
New +$511K 0.03% 127
2021
Q3
Sell
-6,998
Closed -$467K 158
2021
Q2
$467K Buy
+6,998
New +$468K 0.03% 140

Other funds holding HOLX

GW Henssler & Associates's HOLX Position: Q2 2022 in Review

GW Henssler & Associates sold out of Hologic (HOLX) in Q2 2022, closing a stake of 7,058 shares — an estimated $542K sold.

GW Henssler & Associates first reported a position in HOLX in Q2 2021 and held it in 3 quarters. The position peaked at $542K in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • GW Henssler & Associates reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • GW Henssler & Associates sold 7,058 Hologic shares in Q2 2022, an estimated $542K.
  • GW Henssler & Associates first reported a position in Hologic in Q2 2021 and held it in 3 quarters.
  • GW Henssler & Associates's Hologic position peaked at $542K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on GW Henssler & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.